Discontinuation report DEXTROSE INJECTION USP
Report ID | 233046 |
Drug Identification Number | 00037974 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | Dextrose Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000 mL |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-06-30 |
Actual discontinuation date | 2024-07-19 |
Remaining supply date | 2024-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Last lot expires 30-Jun-2024 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-07-20 | English | Compare |
v4 | 2024-07-19 | French | Compare |
v3 | 2024-07-19 | English | Compare |
v2 | 2024-07-16 | French | Compare |
v1 | 2024-07-16 | English | Compare |
Showing 1 to 5 of 5